VR Logo

Accuray Incorporated (ARAY) download report


Healthcare | Medical Devices & Equipment

Accuray Incorporated (ARAY) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region.

IPO Date: 08-Feb-2007

CEO & Director: Mr. Joshua H. Levine

Pres & Director: Ms. Suzanne Winter M.B.A.

Listing: NASDAQ: ARAY

Country: United States

Headquarters: Sunnyvale, CA

Website: https://www.accuray.com

Key Facts

Market cap: $178.18 Mln

Revenue (TTM): $430.82 Mln

Earnings (TTM): $-12.99 Mln

Cash: $97.84 Mln

Total Debt: $201.53 Mln

Insider's Holding: 4.61%

Liquidity: Low

52 Week range: $1.70 - 5.93

Shares outstanding: 92,802,200

10 Years Aggregate:

  • CFO: $-61.95 Mln
  • EBITDA: $-9.71 Mln
  • Net Profit: $-348.81 Mln

Stock Performance

Time Period Accuray (ARAY) S&P BSE Sensex S&P Small-Cap 600
YTD-58.60-8.79-20.11
1 month-7.28-4.72-9.94
3 months-40.87-12.34-15.57
1 Year-55.221.24-18.24
3 Years-20.0210.015.60
5 Years-15.5611.235.34
10 Years-11.5411.779.43
As on 05-Jul-2022
Year Accuray (ARAY) S&P Small-Cap 600 S&P BSE Sensex
202114.3925.2721.99
202047.879.5715.75
2019-17.3020.8614.38
2018-20.60-9.705.87
2017-6.5211.7327.91
2016-31.8524.741.95
2015-10.60-3.36-5.03